Navigation Links
Experimental Weight-Loss Drug Seems to Work: Study
Date:4/11/2011

By Steven Reinberg
HealthDay Reporter

SUNDAY, April 10 (HealthDay News) -- Obese patients taking a high dose of an investigational weight-loss pill called Qnexa lost an average of 22 pounds over a year, while also lowering their cholesterol and blood pressure numbers, a new study has found.

Qnexa is a combination of two medications: phentermine, the most widely used weight-loss drug in the United States, currently available under a variety of brand names as well as a generic; and topiramate (Topamax), best known as a drug used to ease epilepsy and migraine.

Qnexa was recently turned down as a weight-loss aid by the U.S. Food and Drug Administration, because there was not enough data on the risk of birth defects and heart problems related to the drug. Topiramate has been linked to an increased risk for cleft lip/palate in babies born to women who took the drug.

The results of the new study, which was funded by Vivus, Qnexa's maker, suggest that "the combination of topiramate and phentermine when administered with some lifestyle counseling could be a valuable treatment for obesity," said lead researcher Dr. Kishore Gadde, an assistant professor of psychiatry and director of the obesity clinical trials program at Duke University Medical Center.

One reason for the significant weight-loss is that these drugs work by different mechanisms, Gadde said. "In a treatment, [with] the more mechanisms you have there is a greater likelihood of achieving the kind of weight loss we are hoping for, in a large proportion of patients," he said.

In addition, the combination of drugs may alter the side effect profile for each drug, he speculated. "The thinking behind the combination of the drugs is that some of the side effects could actually cancel out," Gadde said. "Topiramate causes fatigue, and phentermine is a stimulant, so they could be negating the side effects of each other."

Topiramate can also cause
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Experimental drug achieves unprecedented weight loss
2. Science at a glance: Symposia, research and special events at Experimental Biology 2011
3. A new experimental diagnostic test able to quickly distinguish infection from tuberculosis disease
4. Extra Tests Not a Deterrent to Experimental Cancer Therapy
5. 2 Experimental Drugs Show Promise for Rare Pancreatic Cancer
6. Experimental approach may improve healing of diabetic wounds and bed sores
7. Study raises safety concerns about experimental cancer approach
8. First liver transplant patients receive experimental drug to prevent hepatitis C infection
9. Experimental Drug Helps Fight Aggressive Breast Cancer: Report
10. Experimental drug more potent, longer lasting than morphine
11. Experimental vaccine sets sights on lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Weight-Loss Drug Seems to Work: Study
(Date:7/6/2015)... News, VA (PRWEB) , ... July 06, 2015 ... ... today that Dr. Jeffrey R. Carlson finished his 100th case using SpineFrontier’s® PedFuse® ... Secours Mary Immaculate Hospital in Newport News, VA. The procedure was an L5-S1 ...
(Date:7/6/2015)... ... July 06, 2015 , ... Thanks to donations and a generous grant ... Music & Memory Certification for hospice patients and adult day center participants. , The ... to patients but also to their families and volunteers. Music & Memory is a ...
(Date:7/5/2015)... MN (PRWEB) , ... July 06, 2015 , ... ... the ancillary benefits market, is excited to announce the next generation of PrimeStar ... and Advantage plans to now include two network options—Maximum Allowable Charge (MAC) and ...
(Date:7/5/2015)... ... July 05, 2015 , ... Women's Excellence in Wellness, powered by ... These classes are geared towards families that want their children to stay active as ... The fitness class will take place TUESDAYS at 4:30pm. Questions? Call 248-601-6683. Women’s ...
(Date:7/5/2015)... , ... July 05, 2015 , ... Women’s Excellence ... college) at their Lake Orion location. The special consists of 2 months of unlimited ... Wellness, powered by Movestrong is located at 1410 South Lapeer Road in Lake Orion. ...
Breaking Medicine News(10 mins):Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... Today the Global AIDS,Alliance Fund responded to the plan ... Dr. Paul Zeitz, Executive Director of the Global ... other experts will discuss the,issue further on a conference ... thrilled to see Senator Clinton,s plan of action on ...
... high-tech identification system,developed in Japan will improve accuracy ... victims of mass disasters, according to a study,presented ... Society of North,America (RSNA)., "Families waiting to ... for the identification process to resolve," said Eiko ...
... dies. It is still not possible to restore the scar ... stem cell researchers attempt to make new heart muscle cells ... Center, however, was able to prove the concept of using ... heart: this cell therapy ensured that less tissue died and ...
... SURGEONS, GREATER ACCESS TO PATIENT DATA AND IMAGES IN THE ... ... ALISO VIEJO, Calif., Nov. 27 Global Care Quest, Inc.,(GCQ), an innovator ... leader in minimally invasive,endoscopic technologies and operating room integration, and GCQ have,expanded ...
... LOS ANGELES, Calif., Nov. 27 Los Angeles, ... Therapy, are joining,forces to create a unique partnership ... cosmetic services., (Photo: http://www.newscom.com/cgi-bin/prnh/20071127/CLTU058 ), ... Laser Hair Therapy, a,safe procedure that assists in ...
... to ... Pharmacopeia, PRINCETON, ... the discovery and development of novel,small molecule therapeutics, announced today that ... with GlaxoSmithKline (NYSE:,GSK), through its collaboration with the Center of Excellence ...
Cached Medicine News:Health News:Senator Clinton's Plan 'The Kind of Leadership We Need on AIDS' 2Health News:New Automated System IDs Victims of Mass Disasters in Minutes 2Health News:New Automated System IDs Victims of Mass Disasters in Minutes 3Health News:KARL STORZ and Global Care Quest Announce Extension of Marketing Agreement 2Health News:KARL STORZ and Global Care Quest Announce Extension of Marketing Agreement 3Health News:Low-level Laser Therapy Clinics' Partnership Targets Helping People Nationwide 2Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 2Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 3Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 4Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 5
(Date:7/6/2015)... 2015 China Information Technology, Inc. (the "Company" ... integrated cloud-based platform, exchange, and big data solutions in ... Company launched its mobile app for Healthcare One Pass, ... on mobile devices. The Company jointly hosted the launch ... Bureau and Shenzhen News Net.   The mobile ...
(Date:7/5/2015)... July 6, 2015 Nihon University is ... on Medical-Engineering Collaboration "Medicine Definitely Jumps Up ... 2015 in Tokyo, Japan . ... applied research will present their achievements and future ... new industry produced with 8K technology. ...
(Date:7/4/2015)... , Spanje, July 4, 2015 ... harsmicrosferen aan eerstelijns chemotherapie voor patiënten met ... (mCRC) verlengt de progressievrije overleving in dat ... gemetastaseerde colorectale kanker (mCRC) die alleen binnen ... gezien in progressievrije overleving (PFS) in de ...
Breaking Medicine Technology:CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5
... 2010 Amicus Therapeutics (Nasdaq: FOLD ), ... diseases, today announced that it has been awarded a ... Parkinson,s Research (MJFF) for the development of a novel, ...  The $500,000 award will be distributed over a period ...
... 2010 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. ... "Company"), which is engaged in the research, development, ... cosmetic products in the People,s Republic of China ... (the "NYSE Amex" or "Exchange") has accepted the ...
Cached Medicine Technology:Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease 2Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease 3Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease 4Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease 5NYSE Amex Accepts China Shenghuo's Compliance Plan for Continued Listing 2NYSE Amex Accepts China Shenghuo's Compliance Plan for Continued Listing 3
Microforceps: Claes ILM Forceps...
The Tano Asymmetrical Microforceps features an offset tip which allows optimal visualization along the entire tip length. Versatile tip design targets ILM, fine epiretinal membranes and diabetic or P...
Microforceps with "nail-like" end-gripping platforms; for precise grasping and improved visualization of thin membranes in the macular region....
Microforceps : Eckardt Endgripping Forceps...
Medicine Products: